Equillium
milestones | Equillium
Company
Deck Type
Sector
Industry
Deck date
February 2024
Slide
39 of 40
Similar slides by Equillium
See diffirences between slides (animation)
Investor Presentation
December 2023
milestones | Equillium
Investor Presentation
November 2023
milestones | Equillium
Investor Presentation
August 2023
milestones | Equillium
Related slides by other companies
Recursion Pharmaceuticals
Investor Day
January 2023
clinical finalize design of a phase enriched trial initiate phase trial in select tumor types in early identify suitable partners for genetic testing capabilities evaluate in combination with targeted and or immune modulating agents next steps | Recursion Pharmaceuticals
Compass Therapeutics
Investor Presentation
February 2023
clinical development plans | Compass Therapeutics
NeuroSense Therapeutics
Investor Presentation
December 2023
strong clinical and commercial potential prime | NeuroSense Therapeutics
NeuroSense Therapeutics
Investor Presentation
December 2023
milestones achieved and upcoming potential catalysts | NeuroSense Therapeutics
Other recent decks by Equillium
See all presentations (5 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Results
September 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights